Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Opexa Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 Jul 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Opexa Therapeutics Inc (OPXA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Jul 2016 Thomson Reuters Stock Report 12 $25.00

ValuEngine Rating and Forecast Report for OPXA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Jul 2016 ValuEngine, Inc. 11 $25.00

OPEXA THERAPEUTICS INC (OPXA=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Jul 2016 Pechala's Reports 2 $25.00

Opexa Therapeutics, Inc. (OPXA) - Financial Analysis Review

Opexa Therapeutics, Inc. (OPXA) - Financial Analysis Review Summary Opexa Therapeutics, Inc. (Opexa) formerly PharmaFrontiers...

19 Jul 2016 GlobalData 57 $300.00

Wright Investors Service Comprehensive Report for Opexa Therapeutics, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

08 Jul 2016 Wright Reports 60 $75.00

OPEXA THERAPEUTICS - MOVING CLOSER TOWARDS ABILI-T DATA IN SPMS

The Abili-T Phase IIb study evaluating Opexa’s Tcelna immunotherapy as a treatment for secondary progressive MS (SPMS) is nea...

29 Jun 2016 Edison Investment Research 8 $10.00

Opexa Therapeutics, Inc. (OPXA) - Financial Analysis Review

Opexa Therapeutics, Inc. (OPXA) - Financial Analysis Review Summary Opexa Therapeutics, Inc. (Opexa) formerly PharmaFrontiers...

17 Jun 2016 GlobalData 57 $300.00

Opexa Therapeutics Final Report

23 May 2016 Taglich Brothers Inc. 4 $12.00

Thomson Reuters Stock Report - Opexa Therapeutics Inc (OPXA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00